Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
Year: 2011
Type: article
Abstract: Ultralow molecular weight (ULMW) heparins are sulfated glycans that are clinically used to treat thrombotic disorders. ULMW heparins range from 1500 to 3000 daltons, corresponding from 5 to 10 saccharide units. The commercial drug Arixtra (fondaparinux sodium) is a structurally homogeneous ULMW heparin pentasaccharide that is synthesized through a lengthy chemical process. Here, we report 10- and 12-step chemoenzymatic syntheses of two structurally homogeneous ULMW heparins (MW = 1778.5 and 1816.5) in 45 and 37% overall yield, respectively, starting from a simple disaccharide. These ULMW heparins display excellent in vitro anticoagulant activity and comparable pharmacokinetic properties to Arixtra, as demonstrated in a rabbit model. The chemoenzymatic approach is scalable and shows promise for a more efficient route to synthesize this important class of medicinal agent.
Source: Science
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
Awards: Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs, Sequencing the Polysaccharide Component of Proteoglycans, Development of a Bioengineered Heparin from a Non-Animal Source, Structural Specificity of Heparan Sulfate for Herpes Infections, In vitro synthesis of recombinant heparan sulfate, Glycomics of Heparan Sulfate in Bacterial Pathogenesis
OpenAlex ID: W2025006097
